AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29258549 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based nutritional counselling by trained Community Health Workers (CHWs) during scheduled visits; specific maternal infant and young child nutrition (MIYCN) messages provided.
Number of subjects: 1110
Study 29258549 — intervention group
Group type: COMPARATOR
Intervention: Control group received standard care from untrained CHWs.
Number of subjects: 1110
Study 29258549 — intervention group
Group type: COMPARATOR
Intervention: Intervention arm (Home-based nutritional counselling) vs Control arm (Standard care)
Number of subjects: 1110
Study 26028449 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive seminar and training of practice nurses
Number of subjects: 313
Study 26028449 — intervention group
Group type: COMPARATOR
Intervention: Interactive seminar without further intervention
Number of subjects: 313
Study 26028449 — intervention group
Group type: COMPARATOR
Intervention: E-learning
Number of subjects: 313
Study 26028449 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of interactive seminar and training of practice nurses
Number of subjects: 313
Study 26028449 — intervention group
Group type: COMPARATOR
Intervention: Practice nurses without continuing medical education
Number of subjects: 313
Study 23550861 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 (1,500 mg daily for 6 months)
Number of subjects: 45
Study 21324167 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planning plus local delivered chlorhexidine
Number of subjects: 98
Study 21324167 — intervention group
Group type: COMPARATOR
Intervention: Supragingival plaque removal only
Number of subjects: 98
Study 19253801 — intervention group
Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 100
Study 19253801 — intervention group
Group type: COMPARATOR
Intervention: Sodium phosphate preparation
Number of subjects: 100
Study 16777857 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 128
Study 16777857 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 128
Study 15141520 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban for 18 hours
Number of subjects: 0
Study 15141520 — intervention group
Group type: COMPARATOR
Intervention: Fenoterol for 18 hours
Number of subjects: 0
Study 15141520 — intervention group
Group type: COMPARATOR
Intervention: Hexoprenalin for 18 hours
Number of subjects: 0
Study 15141520 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban for 48 hours
Number of subjects: 0
Study 15141520 — intervention group
Group type: COMPARATOR
Intervention: Fenoterol for 48 hours
Number of subjects: 0
Study 15141520 — intervention group
Group type: COMPARATOR
Intervention: Hexoprenalin for 48 hours
Number of subjects: 0
Study 21225849 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 0.46 mg/kg dose of cocaine
Number of subjects: 5
Study 21225849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum sHLA-I concentrations in patients with HFRS
Number of subjects: 22
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum sHLA-I concentrations in patients with hypotensive episodes
Number of subjects: 22
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum sHLA-I levels correlation with blood WBC count
Number of subjects: 22
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum sHLA-I levels correlation with serum creatinine concentrations
Number of subjects: 22
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine sHLA-I levels in oliguric phase
Number of subjects: 22
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent elevation of serum sHLA-I
Number of subjects: 22
Study 9159038 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum and urine sHLA-I concentrations
Number of subjects: 22
Study 7667717 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day regimen (300 mg initial dose followed by 100 mg for another 4 days)
Number of subjects: 28
Study 7667717 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day regimen (160 mg initial dose followed by 80 mg daily for another 6 days)
Number of subjects: 28
Study 3498403 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 59
Study 3498403 — intervention group
Group type: EXPERIMENTAL
Intervention: Methohexitone
Number of subjects: 59
Study 3498403 — intervention group
Group type: COMPARATOR
Intervention: Control (Propofol vs Methohexitone)
Number of subjects: 59
Study 3498403 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 59
Study 29745804 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 µg salbutamol (SAL)
Number of subjects: 11
Study 29745804 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 11
Study 26971242 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium HandiHaler®
Number of subjects: 921
Study 26971242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 921
Study 25564322 — intervention group
Group type: EXPERIMENTAL
Intervention: Daikenchuto (DKT) 7.5 g/day, t.i.d. for 3 months
Number of subjects: 81
Study 25564322 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 81
Study 23622445 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 35
Study 23622445 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 35
Study 21320967 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham treatment
Number of subjects: 238
Study 21320967 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 238
Study 18715742 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent Community Reinforcement Approach (A‐CRA)
Number of subjects: 399
Study 16429299 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin 0.8 mg/kg for 4 weeks
Number of subjects: 10
Study 15143418 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (200 micro g)
Number of subjects: 25
Study 15143418 — intervention group
Group type: COMPARATOR
Intervention: Ipratropium bromide (36 micro g)
Number of subjects: 25
Study 10617706 — intervention group
Group type: EXPERIMENTAL
Intervention: NIDCAP
Number of subjects: 25
Study 10617706 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 25
Study 8812752 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) 333.3 ng/min
Number of subjects: 18
Study 8812752 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost 41.7 ng/min
Number of subjects: 18
Study 8812752 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 18
Study 1615182 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxy 500 mg plus bromhexeine 8 mg
Number of subjects: 0
Study 1615182 — intervention group
Group type: COMPARATOR
Intervention: Plain amoxy 500 mg
Number of subjects: 0
Study 6389377 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) after fasting
Number of subjects: 10
Study 6389377 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) with antacid
Number of subjects: 10
Study 6389377 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (50 mg) after a meal
Number of subjects: 10
Study 30262436 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 59
Study 30262436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 28952218 — intervention group
Group type: EXPERIMENTAL
Intervention: Javanica oil emulsion injection (JOEI) combined with radiotherapy (RT)
Number of subjects: 1269
Study 27155958 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored online intervention
Number of subjects: 527
Study 27155958 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary Report Phase
Number of subjects: 527
Study 27155958 — intervention group
Group type: EXPERIMENTAL
Intervention: MI consistent techniques
Number of subjects: 527
Study 25127208 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ponesimod
Number of subjects: 326
Study 25127208 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ponesimod
Number of subjects: 326
Study 25127208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 326
Study 25127208 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg ponesimod (maintenance)
Number of subjects: 326
Study 25127208 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg ponesimod (maintenance)
Number of subjects: 326
Study 25127208 — intervention group
Group type: COMPARATOR
Intervention: Placebo (swapped from 20 mg)
Number of subjects: 326
Study 25127208 — intervention group
Group type: COMPARATOR
Intervention: Placebo (swapped from 40 mg)
Number of subjects: 326
Study 22397386 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-ligating brackets (SL)
Number of subjects: 100
Study 22397386 — intervention group
Group type: COMPARATOR
Intervention: Conventional edgewise twin brackets (CE)
Number of subjects: 100
Study 19773048 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-incision carpal tunnel release (CTR) with <2 cm incision using KnifeLight instrument
Number of subjects: 185
Study 19773048 — intervention group
Group type: COMPARATOR
Intervention: Limited open technique (3-4 cm incision)
Number of subjects: 185
Study 17290061 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide 1.6 g/m2 IV daily for 3 days plus paclitaxel 135 mg/m2 by 3‐hour infusion on day 1 (arm 2)
Number of subjects: 179
Study 17290061 — intervention group
Group type: COMPARATOR
Intervention: Ifosfamide 2.0 g/m2 IV daily for 3 days (arm 1)
Number of subjects: 179
Study 15458510 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (chemo and radiotherapy)
Number of subjects: 218
Study 15458510 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational status
Number of subjects: 218
Study 15458510 — intervention group
Group type: EXPERIMENTAL
Intervention: Income
Number of subjects: 218
Study 15458510 — intervention group
Group type: COMPARATOR
Intervention: Highest vs. lowest education group
Number of subjects: 218
Study 15458510 — intervention group
Group type: COMPARATOR
Intervention: Highest vs. lowest income group
Number of subjects: 218
Study 11471084 — intervention group
Group type: EXPERIMENTAL
Intervention: Health, water and hygiene programmes initiated in the past 16 years
Number of subjects: 2744
Study 9580354 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational groups
Number of subjects: 0
Study 9580354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 9580354 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational groups (first episode patients)
Number of subjects: 0
Study 9580354 — intervention group
Group type: COMPARATOR
Intervention: Control group (first episode patients)
Number of subjects: 0
Study 9580354 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational groups (patients with previous history)
Number of subjects: 0
Study 9580354 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients with previous history)
Number of subjects: 0
Study 7519979 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms in 10 mL of saline)
Number of subjects: 13
Study 7519979 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic porcine galanin (500 micrograms in 100 mL of saline)
Number of subjects: 13
Study 7519979 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine + synthetic porcine galanin
Number of subjects: 13
Study 7519979 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal subjects)
Number of subjects: 13
Study 3287815 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g metronidazole
Number of subjects: 103
Study 3287815 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g metronidazole
Number of subjects: 103
Study 3287815 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g metronidazole + 3 g nalidixic acid
Number of subjects: 103
Study 3287815 — intervention group
Group type: COMPARATOR
Intervention: 1 g metronidazole (3-4 hours preoperatively)
Number of subjects: 103
Study 31391069 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of Event Scale-6 (IES-6)
Number of subjects: 1001
Study 28549439 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal aortic balloon occlusion (AABO) in combination with cesarean section
Number of subjects: 170
Study 28549439 — intervention group
Group type: COMPARATOR
Intervention: Traditional hysterectomy following cesarean section
Number of subjects: 170
Study 25602581 — intervention group
Group type: EXPERIMENTAL
Intervention: ERPonline web-based intervention
Number of subjects: 0
Study 25602581 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 23620949 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 Hz/100 Hz EA treatment group (group B)
Number of subjects: 120
Study 23620949 — intervention group
Group type: COMPARATOR
Intervention: 2 Hz EA treatment group (group A)
Number of subjects: 120
Study 23620949 — intervention group
Group type: COMPARATOR
Intervention: 100 Hz EA treatment group (group C)
Number of subjects: 120
Study 23620949 — intervention group
Group type: COMPARATOR
Intervention: Control group (group D)
Number of subjects: 120
Study 20731584 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone grafting with a xenograft (Group A)
Number of subjects: 100
Study 20731584 — intervention group
Group type: COMPARATOR
Intervention: No grafting material (Group B)
Number of subjects: 100
Study 17964223 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention
Number of subjects: 1036
Study 17964223 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 1036
Study 16939905 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene treatment
Number of subjects: 43
Study 16939905 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 12671829 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral calcitriol pulse therapy (twice weekly for 3 months)
Number of subjects: 48
Study 12671829 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice weekly for 3 months)
Number of subjects: 48
Study 10630940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide in an oral base 0.1%
Number of subjects: 48
Study 10630940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide gel no. 1
Number of subjects: 48
Study 10630940 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide gel no. 2
Number of subjects: 48
Study 9175396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg/kg/dose daily for 3 days)
Number of subjects: 32
Study 9175396 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 8248275 — intervention group
Group type: EXPERIMENTAL
Intervention: Primrose oil (n = 7)
Number of subjects: 18
Study 8248275 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (n = 5)
Number of subjects: 18
Study 8248275 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 18
Study 2940473 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and primidone
Number of subjects: 18
Study 2940473 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study 31935026 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling behavioral intervention promoting consumption of 7 or more daily vegetable servings (MEAL intervention; n=237)
Number of subjects: 478
Study 31935026 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving written information about diet and prostate cancer (n=241)
Number of subjects: 478
Study 31828742 — intervention group
Group type: EXPERIMENTAL
Intervention: Hood oxygen delivery system
Number of subjects: 120
Study 31828742 — intervention group
Group type: COMPARATOR
Intervention: Oronasal mask oxygen delivery system
Number of subjects: 120
Study 28533075 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (20 minutes session)
Number of subjects: 30
Study 28533075 — intervention group
Group type: EXPERIMENTAL
Intervention: LMT (20 minutes session)
Number of subjects: 30
Study 27487637 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonfils intubation fibrescope
Number of subjects: 44
Study 27487637 — intervention group
Group type: COMPARATOR
Intervention: C‐MAC videolaryngoscope
Number of subjects: 44
Study 25175875 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based interventions for schistosomiasis control
Number of subjects: 0
Study 25175875 — intervention group
Group type: COMPARATOR
Intervention: Mass drug administration with praziquantel
Number of subjects: 0
Study 22246963 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized prescribing decision support with patient-specific risk estimates
Number of subjects: 5628
Study 22246963 — intervention group
Group type: COMPARATOR
Intervention: Commercial drug alerts
Number of subjects: 5628
Study 19246726 — intervention group
Group type: EXPERIMENTAL
Intervention: PM101 (150 mg)
Number of subjects: 88
Study 19246726 — intervention group
Group type: COMPARATOR
Intervention: Intravenous amiodarone (150 mg)
Number of subjects: 88
Study 17823420 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, high-fat (LCHF) diet
Number of subjects: 93
Study 17823420 — intervention group
Group type: COMPARATOR
Intervention: High-carbohydrate, low-fat (HCLF) diet
Number of subjects: 93
Study 14747042 — intervention group
Group type: EXPERIMENTAL
Intervention: Estramustine (280 mg tid, days 1 to 5) and docetaxel (70 mg/m2 on day 2) before radical prostatectomy (RP)
Number of subjects: 700
Study 14747042 — intervention group
Group type: COMPARATOR
Intervention: Radical prostatectomy (RP) alone
Number of subjects: 700
Study 14747042 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant estramustine and docetaxel before RP
Number of subjects: 700
Study 14747042 — intervention group
Group type: EXPERIMENTAL
Intervention: RP with and without neoadjuvant estramustine and docetaxel
Number of subjects: 700
Study 10718464 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP intervention
Number of subjects: 63
Study 10718464 — intervention group
Group type: COMPARATOR
Intervention: Antireflux therapy (nizatidine)
Number of subjects: 63
Study 10718464 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (AHI <5.0)
Number of subjects: 63
Study 9177894 — intervention group
Group type: EXPERIMENTAL
Intervention: Trypsin: chymotrypsin (Chymoral forte DS) preparation
Number of subjects: 0
Study 9177894 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 8263885 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroflumethiazide 50 mg and Reserpine 0.125 mg (H-R)
Number of subjects: 49
Study 8263885 — intervention group
Group type: COMPARATOR
Intervention: Chlortalidone 12.5 mg and Atenolol 50 mg (C-A)
Number of subjects: 49
Study 2939815 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous catheter irrigated with antibiotic
Number of subjects: 3282
Study 2939815 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous catheter irrigated with saline
Number of subjects: 3282
Study 2939815 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous catheter alone
Number of subjects: 3282
Study 2939815 — intervention group
Group type: COMPARATOR
Intervention: Primary closure
Number of subjects: 3282
Study 31780023 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil pulling therapy with coconut oil
Number of subjects: 29
Study 31780023 — intervention group
Group type: COMPARATOR
Intervention: 0.2% chlorhexidine gluconate (CHX)
Number of subjects: 29
Study 29920852 — intervention group
Group type: COMPARATOR
Intervention: Morphine 5 mg
Number of subjects: 0
Study 29920852 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 1.5 mg
Number of subjects: 0
Study 29920852 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 0
Study 29920852 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study 29920852 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine in trapezius muscle
Number of subjects: 0
Study 27474943 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 84
Study 27474943 — intervention group
Group type: COMPARATOR
Intervention: Control (no abdominal binder)
Number of subjects: 84
Study 25166443 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine gel (Aqua Touch™) applied immediately before cystoscopy (Group 2)
Number of subjects: 30
Study 25166443 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine gel (Aqua Touch™) applied with a 10-minute clamping before cystoscopy (Group 3)
Number of subjects: 30
Study 25166443 — intervention group
Group type: COMPARATOR
Intervention: Liquid glycerine applied immediately before cystoscopy (Group 1)
Number of subjects: 30
Study 22181580 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate messages
Number of subjects: 80
Study 22181580 — intervention group
Group type: COMPARATOR
Intervention: Inaccurate messages
Number of subjects: 80
Study 22181580 — intervention group
Group type: COMPARATOR
Intervention: Neutral messages
Number of subjects: 80
Study 22181580 — intervention group
Group type: COMPARATOR
Intervention: No messages
Number of subjects: 80
Study 19666195 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy + Treatment As Usual (MBCT+TAU)
Number of subjects: 60
Study 19666195 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 60
Study 18028969 — intervention group
Group type: EXPERIMENTAL
Intervention: FLOTAC technique
Number of subjects: 102
Study 18028969 — intervention group
Group type: COMPARATOR
Intervention: Kato‐Katz technique
Number of subjects: 102
Study 18028969 — intervention group
Group type: COMPARATOR
Intervention: Ether concentration technique
Number of subjects: 102
Study 16202291 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 day miconazole (400 mg/d)
Number of subjects: 300
Study 16202291 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 day miconazole (400 mg/d)
Number of subjects: 300
Study 16202291 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 day miconazole (200 mg/d)
Number of subjects: 300
Study 12891550 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular milk products (calcium supply, 1100 mg/day)
Number of subjects: 32
Study 12891550 — intervention group
Group type: COMPARATOR
Intervention: Placebo milk products (calcium supply, 60 mg/day)
Number of subjects: 32